TCA Concentrations Research Articles

Tracking abiotic transformation of 1,1,1-trichloroethane to 1,1-dichloroethylene in contaminated groundwater on a national scale

1,1,1-trichloroethane (TCA) is a chlorinated aliphatic compound that was increasingly applied as a replacement for trichloroethylene. TCA can simultaneously follow two abiotic degradation processes: hydrolysis and dehydrochlorination, where the latter lead to the formation of a relatively recalcitrant product 1,1-dichloroethylene (DCE). The abiotic processes are relatively rapid and can be assessed based on the ratio between TCA and DCE. Using national data collected in Israel since the year 2000, this work aimed to examine the abiotic degradation extent of TCA nationally and whether it is affected by the aquifer type and unsaturated zone thickness. We have also examined temporal shifts in TCA and DCE concentrations and tested whether they follow expected trends. Our results show that the abiotic degradation of TCA is significant on a national scale, with higher DCE over TCA concentrations in ≈ 89 % of the wells. Furthermore, in ≈ 85 % of the data points, TCA over DCE concentrations indicate that TCA underwent three or more half-lives. Comparing the different lithologies of contaminated groundwater, higher concentrations are observable in karst relative to unconsolidated aquifers. Nevertheless, the ratio between the two and correspondingly the degradation rates are not affected by lithology. Finally, temporal shifts in TCA and DCE concentrations, as well as the ratio between the two, are different than expected in an idealized closed system. Complexities such as lithological heterogeneity, multiple sources, transport parameters, and more must be considered in interpreting these trends when quantification of the degradation rate is attempted.

Earthy/musty odour bioaccumulation in Plecoglossus altivelis grown in a land-based aquaculture fed by reclaimed secondary effluent in wastewater treatment plant

ABSTRACT Reclaimed wastewater (RWW) has been used globally for centuries, though its application in aquaculture is less extensive. Limited study has addressed impacts of RWW-derived volatile odour compounds (VOCs), such as 2,4,6-trichloroanisole (TCA), 2-methylisoborneol (MIB), and geosmin (GSM), on fish quality. This study aims to (1) assess the feasibility of reusing secondary effluent from a municipal wastewater treatment plant (WWTP) for Plecoglossus altivelis aquaculture in a land-based flow-through system and (2) evaluate the sensory effects of selected VOCs on fish quality. Results showed that increased temperature and ammonia levels in summer RWW negatively affected fish growth, while autumn RWW did not. Heavy metals in fish did not cause health issues. TCA, MIB, and GSM concentrations in fish tissues were 4.7–5.7, 0.3–40.5, and 1.1–1.9 mg kg−1, respectively. TCA emerged as the most concerning odorant, with higher relative odour intensity than MIB and GSM in RWW-cultured fish, regardless of seasonal change. This study is the first to report on a self-constructed aquaculture system using RWW at a WWTP, recommending effective VOC and ammonia removal for sustainable RWW use in aquaculture. Additionally, the study highlighted TCA's impact as an anthropogenic indicator in aquatic environments amid increasing WWTP prevalence in developed cities.

Enhanced production of trans-cinnamic acid in Photorhabdus luminescens with homolog expression and deletion strategies.

This study aimed to overproduce industrially relevant and safe bio-compound trans-cinnamic acid (tCA) from Photorhabdus luminescens with deletion strategies and homologous expression strategies that had not been applied before for tCA production. The overproduction of the industrially relevant compound tCA was successfully performed in P. luminescens by deleting stlB (TTO1ΔstlB) encoding a cinnamic acid CoA ligase in the isopropylstilbene pathway and the hcaE insertion (knockout) mutation (hcaE::cat) in the phenylpropionate catabolic pathway, responsible for tCA degradation. A double mutant of both stlB deletion and hcaE insertion mutation (TTO1DM ΔstlB-hcaE::cat) was also generated. These deletion strategies and the phenylalanine ammonium lyase-producing (PI-PAL from Photorhabdus luminescens) plasmid, pBAD30C, carrying stlA (homologous expression mutants) are utilized together in the same strain using different media, a variety of cultivation conditions, and efficient anion exchange resin (Amberlite IRA402) for enhanced tCA synthesis. At the end of the 120-h shake flask cultivation, the maximum tCA production was recorded as 1281mg l-1 in the TTO1pBAD30C mutant cultivated in TB medium, with the IRA402 resin keeping 793mg l-1 and the remaining 488mg l-1 found in the supernatant. TCA production was successfully achieved with homologous expression, coupled with deletion and insertion strategies. 1281mg l-1is the highest tCA concentration that achieved by bacterial tCA production in flask cultivation, according to our knowledge.

Effect of postpartum calcium supplementation on serum calcium and parathyroid hormone concentrations in multiparous Holstein cows

Although postpartum Ca supplementation strategies are often employed to prevent subclinical hypocalcemia in dairy cows, these strategies have produced a mix of beneficial, neutral, and detrimental results when assessing milk yield and subsequent disease outcomes. Because the mechanisms underlying these differing results are unknown, our objectives were to determine how common postpartum Ca supplementation strategies affect blood Ca concentrations and parathyroid hormone (PTH). We conducted a randomized controlled trial with 74 multiparous dairy cows on a commercial dairy in central New York. Cows were assigned to 1 of 4 supplementation groups immediately after calving: (1) control (CON; no Ca supplementation, n = 15); (2) conventional oral Ca supplementation (BOL-C; 43 g of oral Ca bolus administered immediately after calving and 24 h later, n = 17); (3) delayed oral Ca supplementation (BOL-D; 43 g of oral Ca bolus administered 48 and 72 h after calving, n = 15); or (4) subcutaneous infusion (SQ; 500 mL of 23% Ca borogluconate infused subcutaneously once immediately after calving, n = 15). Blood samples were collected immediately after calving (0 h) and at 8, 16, 24, 32, 40, 48, 56, 64, 72, 80, 88, 96, 120, and 168 h postpartum for a total of 15 blood samples per cow. Cows were excluded if administered Ca, via any route, by farm employees or if they died or were sold within 96 h following parturition, which left 62 cows for analysis. Linear mixed models, accounting for repeated measures, were created to analyze changes in serum total Ca (tCa) and PTH over the first 168 h after parturition and assess differences between supplementation groups. Serum tCa and PTH concentrations were not different at the time of calving among supplementation groups. There was a supplementation group by hour postcalving interaction for mean tCa concentration in which SQ cows had reduced tCa concentrations from 32 to 64 h compared with CON cows, 32 to 96 h compared with BOL-C cows, and 40 to 64 h compared with BOL-D cows. Mean PTH concentration did not differ among supplementation groups across 168 h after enrollment and was 158.1 pmol/L (95% confidence interval [CI] = 148.2 to 168.0) for CON cows, 164.0 pmol/L (95% CI = 154.9 to 173.1) for BOL-C cows, 158.7 pmol/L (95% CI = 149.2 to 168.1) for BOL-D cows, and 153.2 pmol/L (95% CI = 143.6 to 162.8) for SQ cows. Our findings suggest that although serum tCa does not differ between cows that receive conventional or delayed oral Ca bolus supplementation at calving and cows that receive no supplemental Ca, subcutaneous infusion of Ca at calving reduces serum tCa for a substantial period between 32 and 64 h postsupplementation. However, as PTH concentrations did not differ among groups across 168 h postpartum, the mechanism by which tCa is reduced remains unclear.

Predictors of blood ionized calcium concentration in sick adult cattle.

Data on the factors affecting blood ionized calcium concentration (ciCa2+ ) and diagnostic performance of serum total calcium concentration (ctCa) measurements to detect abnormal blood iCa2+ status are lacking in sick adult cattle. Assess the association of ciCa2+ with venous blood pH, plasma concentrations of chloride (cCl), sodium (cNa), and potassium (cK), and ctCa, and total protein, albumin, and globulin concentrations in sick adult cattle. Two-hundred and sixty-five adult cattle (≥1-year-old) with different diseases. Prospective study. Whole blood pH, ciCa2+ , cNa, cK, and cCl were measured using a blood gas and electrolyte analyzer, whereas ctCa, and total protein, and albumin concentrations were determined using an autoanalyzer. The relationship between ciCa2+ and venous blood pH, plasma cCl, cNa, cK, and ctCa, and total protein, albumin, and globulin concentrations was investigated. Sensitivity and specificity were calculated for ctCa for diagnosis of abnormal ciCa2+ . Sensitivity of ctCa measurements to detect abnormal ciCa2+ was 66.0% whereas specificity of ctCa measurements was 72.3%. Serum total calcium concentration measurements accounted for 42% of adjusted blood ionized calcium (iCa2+ 7.40 ) concentration variance. Plasma cCl, and cK had explanatory power of ciCa2+ 7.40 , accounting for an additional 21% and 9% of the variance, respectively. Serum tCa measurements failed to accurately predict blood iCa2+ status in ill adult cattle. Serum tCa concentrations and plasma cCl were the strongest predictors of ciCa2+ in sick adult cattle.

Does knowledge of blood calcium concentration at 2 days postpartum affect decisions of calcium supplementation?

Delaying oral Ca supplementation might benefit cows with low blood Ca concentrations at 4 d in milk (DIM), a time when reduced blood total Ca (tCa) is associated with negative health and production outcomes. To implement a targeted approach to manage subclinical hypocalcemia (SCH) at the herd level, it is important to identify which cows benefit from supplemental Ca. Therefore, our objective was to determine if SCH diagnosis at 2 DIM could inform decisions of oral Ca supplementation at 2 and 3 DIM based on milk yield and 4 DIM blood Ca concentration. Data were analyzed from a previously conducted randomized controlled trial on multiparous cows (n = 518) from 4 farms in New York State. Cows were randomly assigned to 1 of 2 treatment groups at calving: (1) control (CON; no Ca supplementation, n = 259) or (2) bolus (BOL; 43 g of oral Ca administered at 2 and 3 DIM postcalving, n = 259). For each parity group (2, 3, 4+), we used generalized linear mixed models to identify serum tCa concentrations at 2 DIM that maximized the difference in milk yield to diagnose SCH. Cows were classified as normocalcemic (NC; parity 2 tCa >1.9 mmol/L, parity 3 tCa >1.87 mmol/L, n = 327; parity ≥4 had no defining threshold) or SCH (parity 2 tCa ≤1.9 mmol/L, parity 3 tCa ≤1.87 mmol/L, n = 58; parity ≥4 had no defining threshold). Parity 2 and 3 cows were further classified into 1 of 4 SCH-treatment groups (SCHTRT) based on 2 DIM SCH status and random treatment allocation: (1) NC-CON, n = 165, (2) SCH-CON, n = 28, (3) NC-BOL, n = 162, or (4) SCH-BOL, n = 30. Generalized linear mixed models were used to analyze the difference in milk yield for the first 10 wk of lactation and tCa at 4 DIM between SCHTRT groups with separate analyses performed for parities 2 and 3. Mean milk yield differed between SCHTRT groups for both parities. For parity 2, SCH-CON and SCH-BOL cows produced more milk than NC-CON and NC-BOL cows with SCH-CON producing 50.9 (95% confidence interval [CI] = 48.4, 53.4) kg/d, SCH-BOL 51.7 (49.1, 54.2) kg/d, NC-CON 47.5 (46.3, 48.7) kg/d, and NC-BOL 47.2 (45.8, 48.5) kg/d of milk. Milk yield was also different between SCHTRT groups for parity 3 with SCH-BOL cows producing more milk than NC-CON and NC-BOL cows. In parity 3, SCH-BOL cows produced 56.3 (95% CI = 53.1, 59.3) kg/d, SCH-CON 51.7 (48.6, 54.7) kg/d, NC-BOL 50.6 (49.0, 52.2) kg/d, and NC-CON 48.7 (46.9, 50.5) kg/d of milk. For both parities, SCH-CON and SCH-BOL cows had lower tCa at 2 DIM than NC-CON and NC-BOL cows. At 4 DIM, tCa concentrations were similar for all SCHTRT groups respective to parity. Our results suggest that although delayed Ca bolus administration does not improve blood Ca concentration when compared with controls, it does support increased milk production in parity 3 cows regardless of Ca status at 2 DIM. Thus, knowledge of blood Ca at 2 DIM should not affect decisions of Ca supplementation in this parity of cows.

Effect of 2 dosages of prepartum cholecalciferol injection on blood minerals, vitamin D metabolites, and milk production in multiparous dairy cows: A randomized clinical trial

The objective of the present study was to evaluate the effect of 2 dosages of prepartum cholecalciferol injection on blood minerals, vitamin D metabolites, and milk production. Cows entering their second or greater lactation (n = 158) were randomly assigned to a control group (CON) or one of 2 treatment groups receiving either 6 × 106 IU (6VitD) or 12 × 106 IU (12VitD) cholecalciferol intramuscularly on d 275 ± 1.2 (SD) of gestation. Concentrations of serum total Ca (tCa), phosphate, and Mg were determined on 1, 2, 3, 5, 7, and 10 d in milk (DIM). For a subsample of 30 cows entering the third lactation (n = 10/group), these samples were analyzed for cholecalciferol, 25-hydroxycholecalciferol (25-OHD3), and 24,25-dihydroxycholecalciferol (24,25-[OH]2D3). In these cows, we also determined 1,25-dihydroxycholecalciferol (1,25-[OH]2D3), the biologically most active metabolite, on 1, 2, 3, and 5 DIM. Repeated measures ANOVA was performed to evaluate the effect of different dosages of cholecalciferol on blood minerals, vitamin D metabolites, and milk yield over the first 5 test days after calving. Binary outcomes such as retained placenta and metritis were analyzed using a chi-squared test. Although the 12VitD treatment increased tCa concentrations on 1, 2, and 3 DIM compared with CON, administration of 6VitD increased tCa concentrations only on 1 DIM. Compared with CON cows and 6VitD cows, 12VitD cows had greater serum phosphate concentration during the first 10 DIM. Furthermore, 6VitD cows had greater serum phosphate concentrations compared with CON cows. On the contrary, 12VitD cows had lower serum Mg concentrations during the first 10 DIM compared with CON and 6VitD cows. Cholecalciferol was increased by the treatment and decreased quickly until 10 DIM. In respect to 25-OHD3, the 6VitD treatment resulted in a 4.1-fold increase in comparison to the CON group, while a 6.5-fold increase was observed in 12VitD animals. The vitamin D metabolite 24,25-(OH)2D3 increased linearly with 25-OHD3 serum levels, resulting in the highest concentrations in the 12VitD group. An increase of 1,25-(OH)2D3 until 3 DIM was observed in all cows. However, this rise was most pronounced in the CON group. The incidence of retained placenta was 1.9%, 11.5%, and 29.6%, and that of metritis was 11.5%, 15.4%, and 31.5% for CON, 6VitD, and 12VitD cows, respectively. Although none of the treated cows exerted clinical signs of hypocalcemia, one cow in CON incurred clinical hypocalcemia. Cows of the 12VitD group had a lower milk yield over the first 5 monthly test days compared with the control and 6VitD group (42.2 ± 0.5, 42.0, ± 0.5 and 40.7 ± 0.5 kg for control cows, 6VitD cows and 12VitD cows, respectively). Although no negative side effects were observed in 6VitD cows, we do not recommend the general application of 6 × 106 IU cholecalciferol before calving as positive effects on calcium homeostasis were marginal and restricted to the first DIM. The present findings confirm that the application of 12 × 106 IU cholecalciferol negatively affected milk production on this farm.

Evaluation of a point-of-care calcium device in bovine plasma and serum

Hypocalcemia is a common metabolic disease in dairy cows, and it is defined as total calcium (tCa) blood concentration <2.0 mmol/L. The alternatives for the gold standard test to measure tCa in bovine blood are limited. Therefore, our objective was to compare the performance of the calcium (Ca) point-of-care compact analyzer (POC; ARKRAY Inc.) device with the gold standard method to measure bovine blood tCa concentration. Blood samples (n = 151) from dairy cows were collected within 24 h postpartum from multiparous and primiparous dairy cows for serum and plasma. Then, serum and plasma were stored at −80°C until further analyses with the gold standard method on an automatic analyzer (Cobas C501 analyzer; Roche Diagnostics) and the POC device. The tCa blood concentration was measured in the laboratory in plasma and serum samples using both methods within 10 mo of sample collection. Correlation coefficients (Spearman), coefficients of variation (CV, %), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, Passing and Bablok regression, and Bland-Altman agreement test were performed between the gold standard and the POC device. The range and median tCa plasma concentrations measured with the POC device were 1.1 to 2.8 mmol/L and 2.4 mmol/L, respectively. The range and median tCa serum concentrations measured with the POC device were 1.1 to 2.7 mmol/L and 2.3 mmol/L, respectively. The tCa blood concentrations range and median with the gold standard were 1.1 to 2.6 mmol/L and 2.3 mmol/L. The hypocalcemia prevalence of our study population was 11.2%. The CV were 1.89% and 0.55% for low and high tCa in plasma samples measured with the POC, respectively. The CV were 2.57% and 1.58% for low and high tCa in serum, respectively. The Spearman correlation coefficient showed a strong correlation between the gold standard and the POC device for both serum and plasma tCa concentration. The sensitivity of the POC device for both plasma (41.1%) and serum (64.7%) Ca was poor. However, the specificity of the POC device was perfect in plasma (99.2%) and serum (99.2%). The PPV in plasma and serum were 87.5% and 91.6%, respectively. Negative predicted values were 93.0% and 95.6% in plasma and serum. The mean (95% CI) difference between the gold standard and the POC device in plasma and serum were 0.35 (−0.52, 1.23) mmol/L and 0.19 (−0.53, 0.92) mmol/L, respectively. Finally, we observed a strong correlation between the POC device and the gold standard method for tCa plasma and serum. However, the clinical application of the POC device should be carefully considered because its ability to detect cows with hypocalcemia in serum or plasma samples was poor. However, the device performed better than previously analyzed POC devices and needs further improvement to be a valuable tool for the dairy industry.

Calcium dynamics and associated temporal patterns of milk constituents in early-lactation multiparous Holsteins

At the onset of lactation, calcium (Ca) homeostasis is challenged. For the transitioning dairy cow, inadequate responses to this challenge may result in subclinical hypocalcemia at some point in the postpartum period. It has been proposed that dynamics of blood Ca and the timing of subclinical hypocalcemia allow cows to be classified into 4 Ca dynamic groups by assessing serum total Ca concentrations (tCa) at 1 and 4 days in milk (DIM). These differing dynamics are associated with different risks of adverse health events and suboptimal production. Our prospective cohort study aimed to characterize the temporal patterns of milk constituents in cows with differing Ca dynamics to investigate the potential of Fourier-transform infrared spectroscopic (FTIR) analysis of milk as a diagnostic tool for identifying cows with unfavorable Ca dynamics. We sampled the blood of 343 multiparous Holsteins on a single dairy in Cayuga County, New York, at 1 and 4 DIM and classified these cows into Ca dynamic groups using threshold concentrations of tCa (1 DIM: tCa <1.98 mmol/L; 4 DIM: tCa <2.22 mmol/L) derived from receiver operating characteristic curve analysis based on epidemiologically relevant health and production outcomes. We also collected proportional milk samples from each of these cows from 3 to 10 DIM for FTIR analysis of milk constituents. Through this analysis we estimated the milk constituent levels of anhydrous lactose (g/100 g of milk and g/milking), true protein (g/100 g of milk and g/milking), fat (g/100 g of milk and g/milking), milk urea nitrogen (mg/100 g of milk), fatty acid (FA) groups including de novo, mixed origin, and preformed FA measured in grams/100 g of milk, by relative percentage, and grams/milking, as well as energy-related metabolites including ketone bodies and milk-predicted blood nonesterified FA. Individual milk constituents were compared among groups at each time point and over the entire sample period using linear regression models. Overall, we found differences among the constituent profiles of Ca dynamic groups at approximately every time point and over the entire sample period. The 2 at-risk groups of cows did not differ from each other at more than one time point for any constituent, however prominent differences existed between the milk of normocalcemic cows and the milk of the other Ca dynamic groups with respect to FA. Over the entire sample period, lactose and protein yield (g/milking) were lower in the milk of at-risk cows than in the milk of the other Ca dynamic groups. In addition, milk yield per milking followed patterns consistent with previous Ca dynamic group research. Though our use of a single farm does limit the general applicability of these findings, our conclusions provide evidence that FTIR may be a useful method for discriminating between cows with different Ca dynamics at time points that may be relevant in the optimization of management or development of clinical intervention strategies.

Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)

IntroductionTricyclic antidepressants (TCAs) have an important role in pharmacotherapy of Major Depressive Disorder (MDD). TCA dosing is aimed at achieving a concentration in the therapeutic window. Due to inter-individual differences in activity of Cytochrome P450 (CYP) 2D6 and 2C19, (enzymes involved in TCA metabolism) patients require an individualized dose. Currently, finding of a suitable dosage is a process of trial-and-error, including multiple drug concentration measurements and dose adjustments. A starting dose based on a patient CYP2D6 and CYP2C19 metabolizer phenotype may contribute to achieving a therapeutic concentration more quickly, possibly resulting in higher treatment efficacy and the occurrence of fewer adverse effects.ObjectivesWe aimed to study whether genotype-informed dosing in TCAs leads to faster attainment of therapeutic plasma concentrations, a higher reduction of depression severity symptoms and less adverse effects.MethodsWe conducted a double-blind randomized clinical trial, in which patients (18-65 years) diagnosed with severe MDD and eligible for treatment with a TCA were randomized in two treatment arms: The intervention arm (Pharmacogenetics Informed Treatment; PIT) and standard treatment (Treatment As Usual; TAU). Patients were treated with nortriptyline, clomipramine or imipramine for seven weeks and depressive symptom severity and adverse effects were monitored weekly. The primary outcome measure, time needed to attain a therapeutic drug concentration, was analyzed using Kaplan-Meier analyses. The secondary outcome measures, reduction in depressive symptoms and adverse effects, were analyzed with mixed model linear regression.ResultsIn total, we randomized 111 patients. The PIT group (n=56) reached a therapeutic plasma concentration significantly faster (Kaplan Meier, X2 (1) = 4.3, p=0.039) compared to TAU (n=55), especially for patients treated with nortriptyline. On average depressive symptoms decreased relatively more in PIT than in TAU, although this was not significantly different: F(6) = 0.45, p = 0.84. The severity of adverse events during the study period differed significantly between PIT and TAU (F(6)=3.10, p=0.008). PIT experienced fewer adverse effects than TAU, especially in the last two weeks of the study.ConclusionsGenotype-informed dosing leads to faster attainment of therapeutic TCA concentrations and does not lead to more adverse effects. Although we were not able to demonstrate that genotype-informed dosing leads to a significantly better response, we conclude that pharmacogenetics can contribute to the optimization of pharmacological treatment. Future research may focus on subgroups for which pharmacogenetics may be of great value, such as specific antidepressants or patients with an abnormal pharmacogenetic profile.Disclosure of InterestNone Declared

A simple method to purify intrinsically disordered proteins by adjusting trichloroacetic acid concentration

Late embryogenic abundant proteins (LEA) are a group of proteins that accumulate during the desiccation phase of the seed and in response to water deficit in the plant. Most LEA proteins are highly hydrophilic and have physicochemical characteristics similar to those of intrinsically disordered proteins (IDPs). Although the function of LEA proteins is not fully understood, there is evidence indicating that these proteins have an important role in reducing the effects caused by water limitation. The analysis of the biochemical and physicochemical characteristics of LEA proteins is crucial to determine their function, for which it is necessary to obtain large amounts of pure protein. Within this current work, we have improved our previous TCA purification method used for basic recombinant LEA proteins to obtain acidic IDPs, the method reported here is fast and simple and is based on the enrichment of the protein of interest by boiling of the bacterial extract followed by a precipitation with different concentrations of TCA and salt. This protocol was applied to acidic and basic IDPs, represented by eight recombinant LEAs, resulting in milligram quantities of highly enriched proteins, which keep their in vitro functionality.

Portable Electronic Nose Based on Digital and Analog Chemical Sensors for 2,4,6-Trichloroanisole Discrimination.

2,4,6-trichloroanisole (TCA) is mainly responsible for cork taint in wine, which causes significant economic losses; therefore, the wine and cork industries demand an immediate, economic, noninvasive and on-the-spot solution. In this work, we present a novel prototype of an electronic nose (e-nose) using an array of digital and analog metal-oxide gas sensors with a total of 31 signals, capable of detecting TCA, and classifying cork samples with low TCA concentrations (≤15.1 ng/L). The results show that the device responds to low concentrations of TCA in laboratory conditions. It also differentiates among the inner and outer layers of cork bark (81.5% success) and distinguishes among six different samples of granulated cork (83.3% success). Finally, the device can predict the concentration of a new sample within a ±10% error margin.

Insulin Sensitivity and Metabolic Flexibility Parallel Plasma TCA Levels in Early Chronotype With Metabolic Syndrome.

People characterized as late chronotype have elevated type 2 diabetes and cardiovascular disease risk compared to early chronotype. It is unclear how chronotype is associated with insulin sensitivity, metabolic flexibility, or plasma TCA cycle intermediates concentration, amino acids (AA), and/or beta-oxidation. This study examined these metabolic associations with chronotype. The Morningness-Eveningness Questionnaire (MEQ) was used to classify adults with metabolic syndrome (ATP III criteria) as either early (n = 15 [13F], MEQ = 64.7 ± 1.4) or late (n = 19 [16F], MEQ = 45.5 ± 1.3) chronotype. Fasting bloods determined hepatic (HOMA-IR) and adipose insulin resistance (Adipose-IR) while a 120-minute euglycemic clamp (40 mU/m2/min, 5 mmoL/L) was performed to test peripheral insulin sensitivity (glucose infusion rate). Carbohydrate (CHOOX) and fat oxidation (FOX), as well as nonoxidative glucose disposal (NOGD), were also estimated (indirect calorimetry). Plasma tricarboxylic acid cycle (TCA) intermediates, AA, and acyl-carnitines were measured along with VO2max and body composition (DXA). There were no statistical differences in age, BMI, fat-free mass, VO2max, or ATP III criteria between groups. Early chronotype, however, had higher peripheral insulin sensitivity (P = 0.009) and lower HOMA-IR (P = 0.02) and Adipose-IR (P = 0.05) compared with late chronotype. Further, early chronotype had higher NOGD (P = 0.008) and greater insulin-stimulated CHOOX (P = 0.02). While fasting lactate (P = 0.01), TCA intermediates (isocitrate, α-ketoglutarate, succinate, fumarate, malate; all P ≤ 0.04) and some AA (proline, isoleucine; P = 0.003-0.05) were lower in early chronotype, other AA (threonine, histidine, arginine; all P ≤ 0.05) and most acyl-carnitines were higher (P ≤ 0.05) compared with late chronotype. Greater insulin sensitivity and metabolic flexibility relates to plasma TCA concentration in early chronotype.

Polymer Film Blend of Polyvinyl Alcohol, Trichloroethylene and Cresol Red for Gamma Radiation Dosimetry.

This study investigated the polymer film composite of polyvinyl alcohol (PVA), trichlorethylene (TCE) and cresol red (CR) dye irradiated with gamma (γ) rays for potential application as radiation dosimetry. The film was prepared via the solvent-casting method with varying concentrations of TCE. Film samples were exposed to radiation from a γ-rays radiation source of 60Cobalt isotope. Color changes before and after γ-rays irradiation were observed, and the optical properties of the polymer films were investigated by spectrophotometry. Results show that increasing the radiation dose physically changed the color of the polymer film, from purple (pH > 8.8) without radiation (0 kGy) to yellow (almost transparent) (2.8 < pH < 7.2) at the highest dose (12 kGy). The concentration of acid formed due to irradiation increased with the increase in irradiation doses and at higher TCE content. The critical doses of PVA-TCE composites decreased linearly with the increase of TCE composition, facilitating an easy calibration process. The dose response at 438 nm increased exponentially with increasing radiation dose, but showed an opposite trend at the 575 nm band. An increase in the TCA concentration indicated a decrease in the absorption edge and an increase in activation energy, but both decreased for all TCE concentrations at higher doses. The energy gap for the direct and the indirect transitions decreased with increasing TCE concentration and γ-rays radiation dose. The results of this study demonstrated the potential application of PVA-TCE-CR polymer film as γ-rays irradiation dosimetry in a useful dose range of 0–12 kGy.

Effects of 25-Hydroxyvitamin D3 and Oral Calcium Bolus on Lactation Performance, Ca Homeostasis, and Health of Multiparous Dairy Cows.

Simple SummarySubclinical hypocalcemia severely affects the lactation and health of dairy cows. Subclinical hypocalcemia is still a concern with cows after postpartum oral Ca; thus, the single treatment approach gradually has shifted to a multitreatment approach in terms of subclinical hypocalcemia. Supplementing 25-hydroxyvitamin D3 could solve the problem of insufficient vitamin D3 synthesis and blocked conversion in transition cows. The present study showed that feeding 25-hydroxyvitamin D3 combined with oral calcium not only improved serum 25-hydroxyvitamin D3 status and calcium homeostasis, but also had potential benefits on lactation performance and the health status during the transition period.Little information is available regarding the effect of supplementing 25-hydroxyvitamin D3 during the transition period combined with a postpartum oral calcium bolus on Ca homeostasis. The objectives of the current study were to evaluate the effects of 25-hydroxyvitamin D3 combined with postpartum oral calcium bolus on lactation performance, serum minerals and vitamin D3 metabolites, blood biochemistry, and antioxidant and immune function in multiparous dairy cows. To evaluate the effects of 25-hydroxyvitamin D3 combined with oral calcium, 48 multiparous Holstein cows were randomly assigned to one of four treatments: (1) supplementing 240 mg/day vitamin D3 without a postpartum oral Ca bolus (control), (2) supplementing 240 mg/day vitamin D3 with an oral Ca bolus containing 90 g of Ca immediately post-calving (Ca + VitD), (3) supplementing 6 g/day 25-hydroxyvitamin D3 without an oral Ca bolus (25D), and (4) supplementing 6 g/day 25-hydroxyvitamin D3 with an oral Ca bolus containing 90 g of Ca immediately post-calving (Ca + 25D). Lactation performance during the first 21 days was measured. Blood was collected at the initiation of calving and then 1, 2, 7, 14, and 21 days relative to the calving date. The yield of milk (0.05 < p < 0.10), energy-corrected milk (p < 0.05), 3.5% fat-corrected milk (p < 0.05), and milk protein (p < 0.05) were significantly higher in 25-hydroxyvitamin D3-treated groups within 3 weeks of lactation than in vitamin D3-treated cows. The iCa (p < 0.05) and tCa (p < 0.05) were higher in both Ca and 25D + Ca cows than in the control and 25D groups within 48 h. The concentrations of serum tCa (p < 0.05), tP (p < 0.05), and 25-hydroxyvitamin D3 (p < 0.05) in 25D and 25D + Ca cows were higher than those in control and Ca cows within 21 days postpartum. Feeding 25-hydroxyvitamin D3 also showed a lower concentration of malondialdehyde (p < 0.05), interleukin 6 (p < 0.05), and tumor necrosis factor-alpha (TNF-α) (p < 0.05), as well as a higher concentration of alkaline phosphatase (p < 0.05), total antioxidant capacity (p < 0.05), and immunoglobulin G (p < 0.05) than vitamin D3. Supplementing Ca bolus also showed lower concentrations of alanine transaminase (p < 0.05) and TNF-α (p < 0.05). In conclusion, supplementing 25-hydroxyvitamin D3 during the transition period combined with a postpartum oral calcium bolus improved lactation performance, Ca homeostasis, and antioxidant and immune function of medium-production dairy cows within 21 days postpartum.

Effects of 25-hydroxyvitamin D3 on growth performance, fecal scores, vitamin D3 metabolites, antioxidant status, and inflammatory and stress-related parameters in weaning calves

The objectives of this study were to evaluate the effects of milk replacers containing 25-hydroxyvitamin D3 [25(OH)D3] and enriched with vitamin D3 on the growth performance, fecal scores, vitamin D3 metabolites, biochemical blood parameters and antioxidant, inflammatory and stress-related parameters of Holstein male calves. Thirty Holstein male calves (body weight = 41.4 ± 2.79 kg) were randomly assigned to three groups for a 56-day experimental period. The control group received milk replacer containing 1.2 mg/kg vitamin D3, the VD group received milk replacer containing 13.2 mg/kg vitamin D3, and the 25D group received milk replacer containing 300 mg/kg 25(OH)D3 plus 1.2 mg/kg vitamin D3 until weaning at day 54. On days 52, 57 and 59, which were defined as days -2, 3 and 5 postweaning, blood samples were collected to measure biochemical blood parameters and antioxidant, inflammatory and stress-related indicators. Calves that received milk replacer containing 25(OH)D3 consumed more calf starter at one week postweaning (P < 0.01) than those in the control and VD groups. Calves in the VD and 25D groups had a significantly (P = 0.02) greater ADG than calves in control during the overall period. Calves in the VD and 25D groups had greater body weight and withers height on day 60 than calves in the control group. Calves fed 25(OH)D3 displayed lower fecal scores and incidence of fecal scores > 2 overall periods. Calves fed 25(OH)D3 had increased serum 25(OH)D3 during the preweaning (P < 0.0001) and postweaning (P < 0.0001) periods. A treatment × time interaction (P < 0.0001) was detected for serum vitamin D3 and 25(OH)D3 in preweaning calves, however, there was no significant time effect on serum vitamin D3 and 25(OH)D3 during the weaning period. Abrupt weaning increased concentrations of total protein, glucose, cholesterol, tCa and tP. Calves fed 25(OH)D3 had a higher tCa (P = 0.04) and tP (P = 0.02) concentrations than those fed other diets. Weaning challenge significantly decreased the CAT concentration and increased the MDA concentration, and calves fed 25(OH)D3 displayed higher GSH-Px and CAT and lower MDA concentrations during the weaning period. Weaning also significantly increased the cytokine contents, including IL-1β, IL-6 and TNF-α, and stress indicators, including cortisol and haptoglobin. Significantly lower cytokine (IL-6 and TNF-α) and stress indicator (cortisol and haptoglobin) contents were observed in calves fed 25(OH)D3 than in those from the VD and control groups at 3 and 5 DPW, respectively. In conclusion, feeding milk replacer with 25(OH)D3 had the potential to improve the growth performance, fecal scores, serum 25(OH)D3, and tCa and tP concentrations of calves, and may reduce weaning stress by enhancing the antioxidant capacity and decreasing the proinflammatory and stress indicators of calves.

Blood calcium as a prognostic indicator of success after surgical correction of left displaced abomasum

Subclinical hypocalcemia, a reduction in blood calcium concentrations without apparent clinical signs of milk fever, occurs in 25 to 50% of early-postpartum dairy cows. Research has shown that these cows are at an increased risk of additional early-lactation diseases, including left displaced abomasum (LDA), compared with their normocalcemic counterparts. However, no work has assessed the association of total calcium (tCa) concentration at the time of LDA correction with subsequent milk yield and survival within the herd. Pending future development of an economical and accurate on-farm test for hypocalcemia, the ability to assess LDA prognosis after surgical correction based on precorrection blood tCa concentration is of interest to practitioners. Therefore, our objective was to determine the association of blood tCa concentration at the time of LDA surgical correction with milk yield and herd removal in the 60 d after correction. Nine bovine practitioners, located in New York State, were involved in sample collection from 17 herds for this prospective cohort study. Immediately following LDA diagnosis and before surgical correction, blood samples were collected from 152 dairy cows within the first 30 d in milk for serum tCa determination. The association of tCa with milk yield (n = 110) and herd removal (n = 127) in the first 60 d after LDA surgical correction was analyzed using repeated-measures ANOVA and a generalized linear mixed model, respectively, controlling for parity and days in milk at LDA surgical correction and the random effect of herd or practitioner. We found no evidence to support an association of tCa at time of LDA diagnosis with subsequent milk yield, and when cows were grouped by median tCa into low and high groups (tCa ≤2.1 and >2.1 mmol/L, respectively), subsequent milk production was similar (39.4 ± 1.6 and 40.1 ± 1.4 kg/d for low and high, respectively). Furthermore, we found no evidence to support an association of tCa at time of LDA diagnosis with the odds of herd removal (odds ratio = 0.6; 95% confidence interval = 0.4–1.7). Therefore, our study provided no clear evidence to support the association of tCa at time of LDA diagnosis and correction with either milk yield or herd removal during the 8 wk after correction. However, it did demonstrate low to extremely low tCa concentration in cows with LDA. Whether calcium supplementation would improve health and production outcomes in these cows is unclear and worth investigating further.

Association of blood calcium concentration in the first 3 days after parturition and energy balance metabolites at day 3 in milk with disease and production outcomes in multiparous Jersey cows

Research exploring specific associations of markers of negative energy balance and Ca in postpartum Jersey cows with lactation performance is lacking. Our objectives were to evaluate the associations of total Ca concentration (tCa) measured at 1 through 3 d in milk (DIM) and free fatty acids (FFA), β-hydroxybutyrate (BHB), and glucose measured at 3 DIM with (1) the risk of multiparous Jersey cows being diagnosed with early-lactation diseases and culling, (2) milk production in the first 9 wk of lactation, and (3) the risk of pregnancy in the first 150 DIM. A cohort study was performed in 1 dairy herd in Texas. Multivariable Poisson regression models were built to evaluate the association of the analytes of interest with the risks of early-lactation diseases and culling in the first 60 DIM (i.e., binary outcomes). Linear mixed models were used to evaluate the association of the analytes of interest with milk production within the first 9 wk of lactation, and a Cox proportional hazard model was built to assess the risk of pregnancy within 150 DIM. A total of 380 cows were used in the final analyses. Total Ca measured at 1 through 3 DIM was not associated with the risk of metritis. Cows with increased FFA and BHB had an increased risk of being diagnosed with metritis and clinical mastitis, respectively. Increased concentrations of glucose and FFA and decreased tCa at 3 DIM were associated with an increased risk of culling. Reduced tCa concentrations at 1 DIM (≤1.84 mmol/L) and 2 DIM (≤2.04 mmol/L) were associated with increased milk production across the first 9 wk of lactation compared with tCa concentrations above those thresholds. Total Ca was not associated with milk production when assessed at 3 DIM, whereas increased FFA (≥0.37 mmol/L) and decreased glucose (≤2.96 mmol/L) at 3 DIM were associated with increased milk production. None of the metabolites measured were associated with the risk of pregnancy in the first 150 DIM. Our results demonstrate that tCa concentration assessed in the first 3 DIM show temporary associations with milk production and culling in multiparous Jersey cows. Although increased concentration of FFA assessed at 3 DIM was associated with greater milk yield, it was a detrimental factor for the risk of metritis. This study attempted to better elucidate the relationship of tCa, FFA, BHB, and glucose assessed in early postpartum with health and performance of Jersey cows. Based on this study, assessments performed at 3 DIM using tCa concentration ≤1.99 mmol/L for increased risk of early-lactation culling and FFA ≥0.43 mmol/L for increased risk of metritis could be used as starting points. More studies evaluating the dynamics of energy balance markers and tCa in postpartum Jersey cows using a greater number of herds are needed to better inform dairy consultants on critical levels for exacerbated postpartum negative energy balance and subclinical hypocalcemia for the Jersey breed.

Određivanje oksidacije proteina u hrani za ribe

This research aimed to develop a reliable, easy-to-perform and cheap method for measuring protein oxidation in complex samples such as aquaculture feed within various protein sources. For that purpose modified 2,4-dinitrophenylhydrazine (DNPH)-based method for quantification of protein carbonyls was employed whilst the modification of the method consisted of using different solutions for the extraction (distilled water and different concentrations of KCl and NaCl solutions), time of protein extraction (after homogenization and over the night) and concentration of trichloroacetic acid (10 and 25% TCA) for protein precipitation. Extraction during the night, higher TCA concentration and the use of 0.5 M KCl extraction solution resulted in the highest protein amount measured by the Lowry method and 280 nm protein estimation. On the other hand, the lowest protein yield was obtained by using distilled water for the extraction. Furthermore, the lowest amount of protein carbonyls was in the case when extraction was performed with distilled water (DW), while the highest content of protein carbonyls was reached with 0.15 M KCl and 0.5 M KCl extraction solutions. It was observed that the amount of proteinbound carbonyls compounds was increasing during storage under accelerated conditions and, in comparison to the original method, the modified method for measuring protein oxidation resulted in a higher amount of carbonyls during all points of storage.

Risk factors associated with disturbances of calcium homeostasis after initiation of a phosphate-restricted diet in cats with chronic kidney disease.

BackgroundDietary phosphate restriction improves survival in cats with chronic kidney disease (CKD). However, feeding a phosphate‐restricted diet may disrupt calcium homeostasis leading to hypercalcemia in some cats.ObjectivesTo identify risk factors associated with increasing plasma total calcium (tCa) concentration after transition to a phosphate‐restricted diet and to explore its role in CKD‐mineral and bone disorder (CKD‐MBD) in cats.AnimalsSeventy‐one geriatric (≥9 years) euthyroid client‐owned cats with International Renal Interest Society (IRIS) stage 2 to 3 azotemic CKD.MethodsRetrospective cross‐sectional cohort study. Changes in plasma tCa concentration in the first 200 days of diet transition were assessed using linear regression. Binary logistic regressions were performed to identify risk factors for increasing calcium concentration. Changes in clinicopathological variables associated with CKD‐MBD over time were explored using linear mixed model and generalized linear mixed model analyses.ResultsLower baseline plasma potassium (odds ratio [OR] = 1.19 per 0.1 mmol/L decrease; P = .003) and phosphate (OR = 1.15 per 0.1 mmol/L decrease; P = .01) concentrations remained independent risk factors for increasing plasma tCa concentration. Plasma creatinine (β = .069 ± .029 mg/dL; P = .02), symmetric dimethylarginine (β = .64 ± .29 μg/dL; P = .03), phosphate (β = .129 ± .062 mg/dL; P = .04), and ln[FGF23] (β = .103 ± .035 pg/mL; P = .004) concentrations had significantly increased rates of change in cats with increasing plasma tCa concentration over time.Conclusion and Clinical ImportanceLower plasma potassium or phosphate concentrations or both at the time of transition of cats with CKD to a phosphate‐restricted diet are independently associated with increased risk of an increase in plasma tCa concentration. Increasing plasma tCa concentration is associated with progression of CKD.